Article
Helping smokers quit through pharmacogenetics.
LDI issue brief - 1 Jan 2000
Lerman Caryn
Abstract excerpt
Recently, the Food and Drug Administration approved a new drug, varenicline, to help people quit smoking. It is the first new smoking cessation drug in nearly a decade, and joins just two other pharmacotherapy approaches [nicotine replacement therapies (NRTs) and bupropion] that have been proven effective for the treatment of tobacco dependence. However, even the most effective treatments help just one in four...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.